BaselinTc99-MIBI scanning predicts survival in multiple myeloma and helps to differentiate this disease from monoclonal gammopathy of unknown significance.
We performed baselineTc(99)-MIBI scanning in 43 patients with multiple myeloma (MM) and in 31 with monoclonal gammopathy of unknown significance (MGUS) patients. We identified two groups of MM patients whose actuarial survival correlated with low or high MIBI scores. MGUS patients had normal or very low scores.
Martín
Martín Gutiérrez
MG
Romero Colás
María Soledad
MS
Dourdil Sahún
María Victoria
MV
Olave
Pilar
P
Alba
Paula Razola
PR
Banzo
Javier Banzo Narraco
JB
D003937:Diagnosis, Differential; D006801:Humans; D009101:Multiple Myeloma / Q000000981:diagnostic imaging* / Q000401:mortality; D010265:Paraproteinemias / Q000000981:diagnostic imaging*; D011237:Predictive Value of Tests; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D016019:Survival Analysis; D017256:Technetium Tc 99m Sestamibi
D019275:Radiopharmaceuticals; D017256:Technetium Tc 99m Sestamibi